Safety and Tolerability Study of MEDI-551, a B-cell Depleting Agent, to Treat Relapsing-Remitting Multiple Sclerosis

HOME | CONTACT | PATIENT LOGIN | CLINIC LOGIN | FAQ

TRIAL ALERTS

Site Listing

Please choose the site that is most convenient for you

Study Name: Safety and Tolerability Study of MEDI-551, a B-cell Depleting Agent, to Treat Relapsing-Remitting Multiple Sclerosis
7 locations found

Research Site
Location: Long Beach, California
Research Site
Location: Denver, Colorado
Research Site
Location: Marlton, New Jersey
Research Site
Location: Winston-Salem, North Carolina
Research Site
Location: Cordova, Tennessee
Research Site
Location: Houston, Texas
Research Site
Location: Seattle, Washington

ClinicalConnection.com is a resource that provides individuals with information regarding clinical trials that are being conducted worldwide.

ClinicalConnection.com does not conduct these clinical trials nor endorse them. Please consult your doctor or physician before participating.

TRIAL ALERTS

HEALTH NEWS

RSS FEEDS

ABOUT TRIALS

LINK TO US

Site Listing